mRNA vaccines like Pfizer and Moderna fare better against COVID-19 variants of concern, new study finds

New study results showed a third mRNA vaccine dose was required to generate a high enough concentration of antibodies to neutralize the BA.2 omicron variant & deltacron…

Innate immune suppression by SARS-CoV-2 mRNA vaccinations

Results of this large cohort study indicated that both first and second doses of mRNA vaccines were associated with increased risk of myocarditis and pericarditis

New study finds vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5–11 years by two-thirds during the Omicron period

Moderna Will Develop mRNA Vaccines for 15 of the World’s Worst Diseases

Study finds mRNA boosters were highly effective against symptomatic delta infection, but they were less effective against symptomatic omicron infection

Patients who received two or three doses of the mRNA vaccine had a 90% reduced risk for ventilator treatment or death from COVID-19

Study using human blood samples suggests antibodies from 2-dose mRNA vaccines against the original SARS-CoV-2 virus & early variants wane substantially over time & offer essentially no protection against omicron

CDC: Receiving 2 or 3 doses of an mRNA COVID-19 vaccine was associated with a 90% reduction in risk for COVID-19–associated IMV or death